URL: http://www.wirednews.com/news/technology/0,1282,40354,00.html
Date accessed: January 8, 2000
10:40 a.m.
Nov. 27, 2000 PST And an Australian biotechnology company, Autogen Limited -- led by a mining
entrepreneur, no less -- will soon be tapping into the first of what it hopes
are many rich Polynesian veins. Autogen has signed an
agreement with Tonga's Ministry of Health to build its own private genetic
database from the 108,000 people of the Kingdom of Tonga. "In most of these countries, what used to be communicable diseases
were the major health problems. All the non-communicable diseases are now
taking over as the more communicable diseases are now under control,"
said professor Greg Collier, Autogen's director of research and development. The Tonga database could allow Autogen to hunt down the genes behind common
diseases such as cardiovascular disease, hypertension, certain cancers and
stomach ulcers. "All these things are appearing as affluence
appears," Collier said. "Now a lot of the South Pacific islands
provide good opportunities to look at these genes appearing in countries that
are being rapidly modernized. And the countries are still relatively
homogeneous in their genetic background." Under the agreement with Tonga -- the only constitutional monarchy in the
Pacific -- Autogen will establish a research facility in Tonga to build up a
genetic database. Autogen won't own any of the samples it gathers -- they'll
remain the property of Tonga -- but it will have exclusive access to the
health database. Collier said Autogen will use information from the database with partners
and other companies to develop disease-specific drugs.
In return for access to these samples and data, Autogen will provide annual
research funding to Tonga's Ministry of Health and royalties on revenues
generated from any discoveries that are commercialized. Later, any
pharmaceutical drugs that are produced and distributed would be given to Tonga
free of charge. Collier won't be drawn on the precise amount of money involved. "We're
going to develop this as quickly as we can," he said, "and it will
be serious money that goes in there."
Collier plans to visit Tonga next month and hopes to start collecting
samples in January 2001. All participation in the project is voluntary, according to the Tonga
Ministry of Health. "We can't force them to take part in the
survey," says the ministry's 'Ahio Tuakoi. And the boss of Autogen Melbourne, mining entrepreneur Joseph Gutnick, is
adamant the whole process will be of the highest ethical standards.
"Hopefully through those studies, done on a very ethical manner, we'll be
able to make new discoveries to enhance the living standard of the people
living in Tonga and also for general humanity," Gutnick was reported as
saying by Radio New Zealand. The Ministry of Health has already identified potential volunteers from
families with high rates of diseases such as cancer. "The study will not
cover the whole population. It is only selected families where the disease is
common, rather than taking the whole population," 'Ahio Tuakoi says. In New Zealand, an extended family with a high rate of gastric cancer
entered an agreement with researchers several years back. Otago
University researchers, who were trying to track down the mutant gene
behind the affected family's illness, agreed to split equally any proceeds
from patents resulting from that work with the family trust.
Dr. Parry Guilford, the senior research fellow on that study, regards
negotiated agreements between the study group and researchers as the only way
to allay concerns over exploitation of smaller, seemingly vulnerable,
communities. "I think there is a growing awareness that individuals or
families do have a major stake in this kind of research," he said. "You kind of get suspicious when you see people going off to little
islands and things and you're going to immediately think there's something
going on which is mischievous," Guilford said. "It's not because
they (the group being studied) are poor and probably uneducated or largely
uneducated that they (the researchers) are doing it. It's because they do
offer this tremendously powerful resource from a genetic viewpoint to actually
go out and find these genes." The Autogen research will have added spinoffs for Tonga: more training and
work for scientists and modern equipment available to the hospital when not in
use for the genetic research. In Tonga so far, according to the ministry, people have no qualms about the
move. "We haven't received any concerns from the public yet so far,"
Tuakoi said. He's hopeful Tongans will see the benefits for the wider community.
"I'm sure people will appreciate the effort for the benefit of the public
at large." Related
Wired Links:
For
genetic researchers, it's the mother lode: an isolated community with an
interesting disease or two.
Sweet
Cure for Rats With Diabetes
Nov. 22, 2000
Good
News, Bad News on AIDS Gene
Nov. 16, 2000
Opening
a Path to Gene Therapy
Nov. 15, 2000
Virtual
Cells May Aid Drug Tests
Nov. 7, 2000
They
See What's in Your Genes
Oct. 27, 2000
Genetic
Data Glut Looms
Oct. 26, 2000
Fear
of a Genetic Underclass
Oct. 24, 2000
Copyright
© 1994-2001 Wired Digital Inc. All rights reserved.